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ABSTRACT
BACKGROUND: Adolescents aged 13-24 account for a substantial number of new HIV
infections every year in the United States. Timely linkage to care and continuous
engagement is very imperative for effective medical interventions and overall improved
health outcomes for HIV positive young adults. This thesis addresses and evaluates the
factors affecting linkage to and retention in care for the newly diagnosed HIV positive
adolescents in Georgia in 2013 and potential solutions to address the disparities.
METHODS: The analysis assessed quantitative and qualitative data extracted from
Georgia’s HIV Surveillance-Electronic HIV/AIDS Reporting System (eHARS), Grady
Infectious Disease Program (IDP), Ryan White CAREWare, and Georgia HIV Testing
Data System. The data analysis was carried out using MS Excel and SAS 9.4. A
univariate analysis was used by cross tabulating variables such as linked to care, any
care, retention in care, and stratified by race/ethnicity, age, and risk factors. Inferential
data was obtained from narrative reports of de-identified client-level from the AntiRetroviral Treatment Access to Services (ARTAS) Intervention. Descriptive statistics
analysis and logistic regression were performed using SAS version 9.4 with significance
set at p<0.05.
RESULTS: Of the total 2,555 newly diagnosed HIV infected persons in Georgia in 2013,
601 were adolescents aged 13-24 years old. In comparison to other age groups,
adolescents had the second highest newly diagnosed rate. Of the HIV infected
adolescents, only 58% were linked to care and 47% were retained in care. HIV infection
was found prominently among Black MSM populations.
CONCLUSION: The results of this study indicated differences in factors and barriers
that are associated with HIV positive adolescents and linkage to medical care and
retention in medical care provide evidence for developing public health interventions.
Public health intervention programs that address sex education, effect of IV drug use,
and the importance of health insurance may help curb the prevalence of both HIV and
sexually transmitted diseases in at-risk groups.
KEY WORDS: adolescents, youth, antiretroviral therapy (ART), HIV prevention, HIV
counseling and testing (C&T), viral suppression, barriers, linkage to care, retention in
care.
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CHAPTER I
INTRODUCTION
1.1 Background
Thirty-four years into the human immunodeficiency virus (HIV) epidemic in the
United States, an estimated 50,000 persons become infected annually. Despite efforts
to date, adolescents and young people aged 13-24 years old continue to be susceptible
to HIV infection.8 The Centers for Disease Control and Prevention (CDC) estimates that
26% of the approximately 50,000 new HIV infections diagnosed in 2010 were among
the 13 to 24 years of age group. Over 100,000 adolescents aged 13-24 are currently
infected with HIV.8 Linkage to care for newly diagnosed HIV-positive adolescents is an
important consideration as the United States HIV epidemic shifts toward younger
individuals.
The number of people with undiagnosed HIV in Georgia is not known but the only
way to know for sure if one is infected is to be tested. Timely entry into medical care is
important for treatment of HIV and secondary medical illnesses. Linkage to care is the
process of connecting a client from one service system to another, in this case from HIV
testing to HIV care. Some persons never return for further HIV care after initial
diagnosis and linkage. Retention in care reflects the recommended standard of care
with at least two HIV care visits at least three months apart in a year.33
Viral load and CD4 count are closely monitored when beginning HIV treatment.
These two counts express virus progression, therapy response, and help determine HIV
treatment. A viral load of <200 copies/ml is crucial when preventing HIV progression to
AIDS and to diminish viral transmission. Studies have shown that viral suppression
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reduces transmission by 96%. 39 Overall, not being retained in care or having
inconsistent medical visits is associated with higher mortality.
Adolescents are correlated with a low percentage of retention in care during the
first two years following diagnosis and HIV-diagnosed persons younger than 35 years of
age have more difficulty establishing and being retained in care.27 Of the HIV-infected
youths, approximately 41% of HIV-infected youth in the United States are aware of their
diagnosis, while only 62% of those diagnosed engage medical care within 12 months of
diagnosis.64 Access to and uptake of HIV counseling and testing (C&T) by adolescents
is significantly lower than for adults.
The Centers for Disease Control and Prevention advocates routine screening for
HIV infection in clinical settings.15 The implementation of this recommendation has been
continuously remaining to a variety of concerns such as lack of awareness and
misunderstandings related to HIV screening by physicians and patients, barriers at the
facility and legislative levels, costs associated with testing, and conflicting
recommendations concerning the value of routine screening. Eliminating these barriers
is needed to increase the implementation of routine screening in clinical settings so that
more people with unrecognized infection can be identified, linked to care, and provided
treatment to improve their health and prevent new cases of HIV infection among
adolescents in the United States.
1.2 Purpose of the study
The purpose of this analysis is to examine the HIV Care Continuum methodology
used to describe linkage to care and retention in care initiative for HIV-positive
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adolescents aged 13-24 in Georgia in 2013 and discuss implications of low percentages
of viral suppression for HIV prevention adolescents and possible barriers behind the
outcomes. The analysis will be assessing data extracted from Georgia's HIV
Surveillance-Electronic HIV/AIDS Reporting System (eHARS) and Georgia HIV Testing
Data System in 2013 evaluating variables such as linked to care, retention in care, viral
suppression, and stratified by race, ethnicity, age, and exploring other supporting risk
factors.
Adolescents are developmentally at a challenging crossroad because of their
need for independence and the reality their decision-making ability competes with their
concrete thinking processes, risk-taking behaviors, and concern with self-image. This
makes it perplexing to draw and sustain adolescents’ attention on maintaining their
health. Thus, every effort must be made to engage and maintain adolescents in care so
they can improve and maintain their health for the long term.
1.3 Research Questions
1. What social and structural disparities affect adolescents from engaging in HIV
medical care?
2. How do these disparities among adolescents frame an outcome of the
engagement in HIV medical care?
3. How do existing data collection systems support targeting and monitoring for
those who need HIV services the most?
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CHAPTER II
REVIEW OF THE LITERATURE
The literature review focuses on examining factors that have been found to be
associated with increase susceptibility for lack of medical care. Studies that discuss the
characteristics and distribution of HIV positive persons are also noted. Finally, the effect
of different risk factors related to HIV and sexually transmitted diseases are discussed.
2.1 HIV Testing Challenges Among Youth
Most new HIV infections among youth occur among gay and bisexual males and
accounted for a 22% increase in estimated new infections in this group from 2008 to
2010. Over 50% of youth with HIV in the United States do not know they have the
infection.34 Early detection of HIV infection facilitates people to start treatment sooner
and leading to better health outcomes and longer lives. Studies show that people who
know they contracted the illness are far less likely to have unprotected sex than those
who do not.32 HIV testing presents an essential opportunity to educate people on how
they can protect themselves and others from HIV/AIDS and other sexually transmitted
diseases (STDs).
With the increasing numbers of people with HIV/AIDS and missed opportunities
for HIV testing, the Centers for Disease Control and Prevention recommends universal
and routine HIV testing for all patients seen in healthcare settings. The epidemiologic
data recommends that routine screening to be offered to all adolescents at least once
by 16 to 18 years of age in healthcare settings where the prevalence of HIV in the
patient population is more than 0.1%.18 In areas of lower community HIV prevalence,
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routine HIV testing is encouraged for all sexually active adolescents and those with
other risk factors for HIV. This paper addresses any of the actual and perceived barriers
that providers face in promoting routine HIV testing for their patients.
The CDC’s national Youth Risk Behavior Survey (YRBS) is a school-based
survey that monitors health risk behaviors among high school students. The survey
provides data on the percentage of students in grades 9–12 who have been tested for
HIV.72 Since 1985, more than 6,600 cases of AIDS among youth aged 13–19 have been
reported. By the end of 2006, Youth Risk Behavior Survey (YRBS) estimated 56,500
young people aged 13–24 years old were living with HIV infection or AIDS.
Approximately 19,200 adolescents and young adults aged 13–29 were newly infected
with HIV during 2006. This age group represented about 34% of all new HIV infections
that year.72 Certain subpopulations are disproportionately affected by HIV/AIDS,
including young men who have sex with men (MSM), African Americans, and Hispanics.
According to the 2007 YRBS, 13% of 9th–12th grade students had ever been
tested for HIV. Testing rates varied by sex (15% among female students and 11%
among male students), race/ethnicity (22% among black students, 13% among Hispanic
students, 11% among white students), and grade (9% among 9th graders, increasing to
19% among 12th graders). According to the 2013 national YRBS, 13% of 9th–12th
grade students had ever been tested for HIV, which is the same from 2007’s survey.21
HIV testing has additional public health benefits because it has shown to reduce
sexual risk behaviors when implemented with client-centered prevention counseling.
Much progress has been made in the area of HIV testing with the help of rapid and less
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invasive diagnostic HIV tests that are available. The gold standard is an immunoassay,
which tests for the antibodies that your body makes against HIV.68 The immunoassay
may be conducted in a lab or as a rapid test at the testing site. It may be performed on
blood or oral fluid. Because the level of antibody in oral fluid is lower than it is in blood,
blood tests tend to find infection sooner after exposure than do oral fluid tests. There
are other types of HIV testing which are used once a person has been diagnosed with
the virus, such as the CD4 test and the viral load test.34
Teens and young adults prefer rapid HIV testing that can deliver results in less
than an hour but some still worry about whether their tests will be confidential, according
to Journal of Adolescent Health.3 A third of the teens from a Boston clinic for HIV testing
surveyed preferred completely free HIV testing but many teens said they would be
willing to contribute at least $10 toward the cost of a future rapid HIV test. However,
39% said they had some concerns that their parents and health insurers would discover
their results. The strong support for rapid HIV testing by adolescents was encouraging
to fellow researchers at Children’s Hospital Boston.3 Few adolescents know where to
undergo testing and those who get conventional tests rarely return for their results one
to two weeks later.12
Most of the people who wanted free tests at the Boston clinic were women and
the average age of the patients seeking HIV testing were 20 years old. Rebecca
Swenson, Ph.D., an assistant professor of psychiatry and human behavior at Brown
University who has studied other barriers to HIV testing among youth, said that “the
context of a relationship” could also influence an adolescent’s willingness to undergo
testing.3 Youth who use condoms inconsistently with a serious partner were nearly four
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times more likely to accept testing than those reporting multiple sex partners. Sexually
active teens that are not in relationships are less likely to accept testing despite
potentially being at greater risk for HIV exposure. Some youth only test if it’s free or if
rapid testing is available. A Boston study suggests that health care clinicians might have
to engage in some creative solutions to make teen HIV testing more routine, such as
using alternate billing codes for the test to provide more confidentiality to the patients.13
Cathryn Samples, M.D., who heads the HIV adolescent program at Children’s
Hospital in Boston, believes providers should be more attentive when providing posttest counseling and medical follow-up, and approach unconventional options to routine
testing because youths were less likely to be inclined to discuss test results with
medical professionals.3 Older youths were more likely to know about the different testing
methods whereas younger patients were more quick to say they were scared of tests
involving needles and knew less about the different testing choices available to them.41
2.2 HIV Transmission Among Youth
Most young adults aged 13-24 years old acquire HIV through sexual risk
behaviors. Many of them are recently infected and unaware of their HIV infection status.
Thus, many are in an early stage of HIV infection, which makes them ideal candidates
for early interventions, such as prevention counseling and linkage to and engagement in
care. A cohort of youth aged 13-24 years old identified as HIV infected by adolescent
HIV specialty clinics in 15 major metropolitan cities in the United States reported to have
high-grade viremia. The mean HIV viral load for the cohort was 94,398 copies/ml and
30% of the 988 adolescents in the cohort study were not successfully linked to care.54
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Another study among HIV infected adolescents and young adults in attendance
for HIV care noted primary genotypic resistance mutations to antiretroviral medications
in up to 18% of the evaluated sample of recently infected youth determined by the
antibody testing assay within 180 days of testing. In addition to this study, considerable
multiclass resistance was distinguished in the youth cohort.10 This transmission dynamic
reveals that a substantial proportion of youth’s sexual partners are likely older and may
be more antiretroviral therapy experienced. Also, this transmission dynamic puts a need
for awareness on resistance testing among recently infected youth naive to antiretroviral
therapy is crucial.55
Many adolescents engage in sexual intercourse with multiple partners and
without condoms. Consequently, they engage in sexual behaviors that place them at
risk of sexually transmitted diseases (STDs), including HIV. Among sexually active
people, adolescents aged 15 to 19 years have some of the highest reported rates of
STDs. In addition, particular groups of adolescents, such as males who have sex with
males, injection drug users, and teens that participate in sex for drugs, engage in even
greater risk-taking behavior. An estimated 25% of all people with HIV in the United
States contracted HIV when they were young adults aged 13-24 years old.40
Globally, an estimated 11.8 million youth aged 15-24 was living with HIV by mid2002. Almost 50% of all new HIV infections worldwide, or approximately 6,000 per day,
occur among young adults.51 Because many HIV-infected young adults have not been
tested for HIV and their HIV status is not known due to the long latency period before
development of clinical AIDS, many cases of HIV/AIDS that are identified among people
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in their 20’s or even early 30’s may have been acquired during their teen years or in
their early 20s.46
Despite the challenges of determining at what ages HIV infection occurs, the
U.S. Office of National AIDS Policy has estimated that half of all new HIV infections
occur in people under 25 and that half of these occur among young people between the
ages of 13 and 24.40 The risk for getting HIV is higher in communities where a higher
percentage of people already have HIV because partners are more likely to be infected.
African Americans have a greater burden of HIV than other racial or ethnic groups in the
US so they are at higher risk.29 Gay and bisexual men are forty times more likely to
have HIV than other men. Studies indicate that young gay and bisexual males who have
sex with older partners are at a greater risk for HIV infection.45This is because an older
partner is more likely to have had more sexual partners or other risks, and is more likely
to be infected with HIV.
Among new cases of HIV infection reported among 13 to 24 year old men in the
United States in 2001, 48% were among men who have sex with men, 3% were among
men who injected drugs, 3% were among men who both had sex with men and injected
drugs, and only 6% were among men who were exposed through heterosexual
contact.72 Among new cases of HIV reported among young women aged 13-24 years,
33% of the exposure category was heterosexual contact.41
Simply providing facts about HIV transmission and prevention or promoting
abstinence is not enough for adolescents. Both substance use and emotional
unpreparedness of sexual intimacy impairs judgment in risky situations and putting

	
  

10	
  

youth at increased risk for unplanned pregnancy and infection with HIV and other STDs.
Youth frequently receive incorrect information from their peers which may give them the
false sense that they are invulnerable or already protected. The risk for HIV for most
adolescents begins when they start having sex or injecting drugs.71 For both males and
females, having sex under the influence of drugs or alcohol can increase risky
behaviors that could lead to becoming infected with HIV.
According to a national survey conducted by the American School Health
Association, approximately 25% of 8th grade students and nearly 40% of 10th grade
students report having five or more alcoholic drinks on one occasion during a two-week
period. In addition to these statistics, one out of every 15 adolescents has tried
cocaine.12 Even when drug use does not involve needles, alcohol and other drug
consumptions impairs judgment, which may lead to unprotected sexual activity. As with
alcohol and other drug use, many young people do not consider the consequences of
unprotected sexual intercourse.29
For most adolescents, the decision to have intercourse is spontaneous where
only 17% of young women and 25% of young men report planning their first act of
intercourse.12 Unprotected sexual intercourse causes serious consequences for youth.
Approximately one in every five adolescent contracts an STD every year. A 1992 CDC
study shows people with a history of STDs and the resulting open sores can facilitate
the transmission of HIV and have a higher rate of HIV infection than those with no
history.15
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Although most high school students know the major modes of HIV transmission,
misconceptions about the risk of contracting HIV from toilets, donating blood, and insect
bites still remain. Also, the misconception of the efficacy of oral contraceptive use in
preventing the transmission of HIV and the ability to identify those who are HIV positive
by looking at them persist.71 These misconceptions mislead adolescents about the
proper precautions to take to prevent HIV infection and instead put them at a greater
risk of infection.
Despite studies that have determined the majority of adolescents have much of
the information they need about the dangers of alcohol, drug user, and unplanned
unprotected sexual intercourse, risky behaviors among young adults are still resistant to
change. In a CDC study, 49.4% of sexually active males and 40% of sexually active
females in high school reported they used a condom during their last act of sexual
intercourse. Less than half, 44% of gay and bisexual males in high school used
condoms the last time they had sexual intercourse.1 This is evident information alone is
not sufficient for teenagers to feel personally at risk and these statistics suggest
targeting adolescents perceptions of vulnerability is necessary to motivate behavior
change.
2.3 Perceived Barriers to Medical Care for Adolescents
HIV infection among adolescents is also most likely to be under-reported
because adolescents commonly lack access to medical care for HIV diagnosis and
treatment.14 Barriers to care have individual and structural roots. Several interventions
for linkage to care are focused on the individual with varying levels of success.14 Less
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attention, however, has been given to “structural barriers” and factors impeding HIVrelated care that originate in the social, economic and political disparities that shape and
constrain individual health behaviors.29 Structural barriers include HIV-related stigma
and poverty, housing availability and homelessness, unemployment or job instability,
insurance policy/eligibility, and public transportation options.64
Structural barriers are particularly relevant for HIV-positive adolescents who often
have difficulty navigating fragmented care systems.15 This structural fragmentation can
occur when HIV testing sites fail to plan for long term care, when adolescents must
negotiate transitions across multiple care systems, when legal or regulatory issues
require disclosure to parents, and when providers are unprepared to care for HIVpositive adolescents.49
Research has found that youth might forgo reproductive health services if
parental consent is required. Laws concerning consent and confidentiality for HIV care
and treatment vary among states; thus, physicians need to familiarize themselves with
local laws.50 Public health statutes and legal precedents allow for medical evaluation
and treatment of minors with certain illnesses, especially STDs, without parental
knowledge or consent. Consent and confidentiality laws, even for the treatment of
STDs, may have special provisions in some states for teenagers in foster care. Minors
can now consent to HIV testing in all states, although the age of consent varies,
pediatricians need to know and abide by the laws in effect in their jurisdiction.60
Adolescents maybe particularly likely to receive HIV testing in community-based
rather than clinic-based venues, and given the fragmentation between diagnosis and
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care, rates of successful linkage to care are lower in community-based settings
compared to clinic-based settings.2 Relatively few HIV-related health services are
specifically designed for adolescents, even though adolescents differ from adults in their
ongoing dependence on families for resources, health insurance, transportation, and
access to clinics and pharmacies.
A study highlights macro, meso, and micro-levels of structural barriers to linkage
to care for HIV positive adolescents. Macro-level barriers include navigating health
insurance policies, transportation to appointments, and ease of collecting and sharing
client-level contact information between testing agencies, local health departments, and
clinic. Adolescents and young adults, especially poor and minority, are over-represented
in the approximately 10% of American children and adolescents without healthcare
insurance of any kind.6 Lack of insurance also limits subsequent care engagement of
newly diagnosed youth, especially if alternative means of payment are unavailable.48
Findings from other research show that transportation is uniformly cited as
macro-level barrier to care, especially in areas with fragmented and limited public
transportation systems.54 Reduced cost or free transportation services for HIV-positive
patients have been shown to improve HIV-related health outcomes.28 However, our data
demonstrate the difficulty of provision of transportation, particularly in a resource-limited
time, that is associated with HIV-related care.
Meso-level barriers included lack of youth friendliness within clinic space and
staff, and duplication of linkage services. This level of barrier also is affecting linkage to
care focused on physical space and the attitudes and behaviors of clinic personnel.
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Other studies have shown that staff attitudes often communicate larger social values of
homophobia and HIV-related stigma.50 The concept of adolescent friendliness reflects
the importance of creating spaces where HIV-positive adolescents feel secure and not
judged.61 However, few studies aside from results stemming from this program have
directly assessed what constitutes adolescent friendly qualities of clinics providing HIVrelated care.62
Micro-level barriers included adolescents’ readiness for care and adolescent
developmental capacity. Micro-level level factors, such as individual readiness for care,
have the potential to directly affect linkage to care. These data showed that linkage to
care often required flexibility and persistence in maintaining contact with adolescents
not yet ready to engage in HIV care. Though often seen as a structural issue, the stigma
that results from an HIV diagnosis, the fear of rejection by family, peers, and community
has individual implications.48 Development of self- and social-identities during middle
and late adolescence additionally affect the acceptance of the HIV diagnosis, which is
associated with higher rates of depression, anxiety, social isolation, and stigma among
HIV-positive adolescents.64
Adolescents are less likely to have health insurance than those of any other age
group. In addition, people living with HIV are more likely to experience poverty and lack
health insurance when compared with their uninfected counterparts. Studies and data
show both behaviorally and perinatally infected youth, as well as pediatric and
adolescent HIV care providers, find insurance issues to be a significant barrier to the
transition process into medical care.5 In one study, perinatally infected youth expressed
concerns about access to quality providers caused by parental insurance changes,
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whereas in another study of behaviorally infected youth, 20% of the participants
specifically reported delays in accessing an adult provider because of difficulty
navigating an insurance referral system.61
Gaps in health insurance coverage and other economic or transportation
barriers may lead to missed appointments during transition, which in turn has been
associated with rebound in viral load and clinically significant resistance. In addition,
some behaviorally infected youth may also experience a “functional” loss of coverage if
they are hesitant to access care because of not wanting to disclose their status to a
parent or guardian who may be the primary beneficiary of the plan.61
Many adolescents living with HIV experience rejection, violence, discrimination,
or other poor treatment as a result of disclosing their HIV diagnosis. Concerns about
stigma and disclosure may be particularly prominent for young adults living with HIV
during health care transition.14 Several studies have specifically documented that
perinatally infected youth and their pediatric care providers are concerned about
transition to the adult health care environment because they may experience
discrimination from providers or other patients. This discrimination is to be related to the
stigma that is prevalent and directed toward people who acquired HIV through risk
behaviors including sexual activity or intravenous drug use.11
Similar apprehensions about stigma and fear of consequences of disclosure of
diagnosis have been documented in the literature among different populations of
behaviorally infected HIV positive adolescents including intravenous drug users and
men who have sex with men.11 Status disclosure is also a distress in this transitional
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process. Behaviorally infected youth and their adolescent providers have reported they
fear their status will be accidentally disclosed by forcing them to get their health care in
facilities labeled as “infectious disease” clinics.18 Their pediatric or adolescent HIV care
is more likely to afford them a higher degree of anonymity and confidentiality.
2.4 Constituents Shaping Adolescents in Medical Care
There is an increasing trend toward earlier initiation of ART. However, even with
the trend to treat all HIV infected individuals, significant barriers for successful ART
treatment remain. Foremost, adolescents with HIV must be aware of their status and
engage in care. Their physicians must be willing to accept potential barriers such as
erratic lifestyle, substance abuse, unstable housing, and nondisclosure prior to initiating
youth on life-long ART. Once in care, patients must remain in care and maintain a high
degree of adherence to ART.
Despite this, patients may experience baseline viral resistance or could develop
resistance due to poor adherence, drug–drug interactions, medication side effects,
malabsorption of the medication, or any other factor that can cause delayed low serum
blood levels of ART. A large national U.S. study found 14% of the 856 adolescents and
young adults aged 13–29 years had transmitted resistance compared to 15% for the
entire cohort. Another multisite study of 130 HIV-infected young adults aged 18–24
found 9.2% carried transmitted HIV resistance mutations.50 Even with universal ART
treatment, a significant portion of those who initiate therapy may not respond to typical
first-line regimens.
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Although recent studies with newer ART regimens have suggested high levels of
viral suppression in adults, adolescents and young adults do not appear to achieve this
goal. Recent first-line viral suppression rates after Highly Active Antiretroviral Therapy
(HAART) initiation for adolescents in clinical trials report suppression rates as high as
86%. 53 However, observational studies report lower suppression rates ranging from
46% to 59%. Comparatively, adult first-line ART regimens report viral suppression rates
between 79% in observational studies and 85–98% in clinical trials. By combining
recent studies of potent ART regimens in adolescents and young adults, we estimate
that only 51% achieve viral suppression to less than 400 copies/ml.52
During adolescence, youth with chronic illness commonly go through periods of
poor adherence to medical regimens. Several studies have found poor viral suppression
rates or poor adherence among HIV-infected adolescents. Among HIV-infected
adolescents, barriers to adherence include medical, psychological, and logistical
reasons.61 Medical barriers shown to affect adherence in youth include an AIDS
diagnosis, a difficult ART regimen, absence of symptoms, side effects of medication,
and dissatisfaction with the health team/system.54 Logistical barriers such as forgetting
medication doses, travel, and inconvenience/inconsistent routine, commonly affect
adherence in youth. Psychological barriers including depression/anxiety, perceived
stigma, lack of support, behavioral and conduct problems are present in more than 50%
of HIV-infected youth.
In order to sustain viral suppression while receiving antiretroviral therapy, it is
essential to remain engaged in regular medical care. The ARTAS study found young
adults aged 18 to 24 were significantly less likely (52%) to be retained in care than
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adults (59%) at one year of treatment (p=0.02). Another study found age was
significantly associated with lack of retention in care in which 41% of those younger
than age 25 were retained compared to 75% of those over 25 years old. A study from
South Carolina found that only 31% of those aged 18–24 years were retained in care
over 3 years.61 Others have also found low retention rates in young adults. Combining
published data on adolescents and young adults, we estimate that 43% are retained in
care over 1–3 years.63
Improvement in antiretroviral therapy has changed perinatal HIV infection from a
terminal disease into a chronic, manageable infection requiring medication adherence.
This presents an additional challenge for many perinatally infected and younger
behaviorally infected adolescents cared for in pediatric or adolescent facilities that must
transition to adult care in their late teens or early twenties. Although HIV infected youth
are more likely to have cognitive impairment and mental health problems, they are less
likely to receive coordinated care in adult-oriented facilities. In addition, transition to
adult services has been associated with lapses in adherence and worse clinical
outcomes for adolescents with chronic illnesses. Changing of care providers, lack of
youth-friendly services, rigid scheduling, increasing responsibilities, and decreasing
involvement of adult caregivers all contribute to the challenges of transition care for
adolescents and young adults.
2.5 HIV Care Continuum
The HIV Care Continuum has become a fundamental in the public health world
for the care of patients with HIV/AIDS. This paper addresses the phases that make up
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the care continuum as linked to care, retained in care, and viral suppression. The term
“linked to care” refers to process of assisting HIV-diagnosed clients into medical care
within 3 months of diagnosis between January 1, 2013 and December 31, 2013. The
term “retained in care” refers to having at least two CD4 or VL at least 3 months apart in
2013. Viral suppression refers to having a VL of less than 200 copies/ml in the most
recent VL in 2013. Each stage in the continuum is independent of those preceding it
and all percentages are of the total number of persons (N) diagnosed with HIV in each
category.
Despite differing descriptions for the HIV care continuum, the outcomes carry
similar trends. The continuum focuses on several steps of HIV medical service delivery,
including diagnosis, linkage to care, retention in care, ART, and viral load suppression.
The HIV Care Continuum provides a framework to better understand HIV care and
treatment in the United States. Data suggest that without significant improvements at
each stage of the HIV Care Continuum, more than 1.23 million new HIV infections could
occur in the United States over the next 20 years.67 The obvious decline between
linkage to care and retention in care shows that these are serious intervention points for
scaling up ART coverage and capitalize on public health and clinical benefits.
2.6 Anti-Retroviral Treatment and Access to Services (ARTAS)
ARTAS or Anti-Retroviral Treatment and Access to Services is a Linkage Case
Management System. ARTAS is an individual-level, multi-session intervention for
people who are recently diagnosed with HIV or have fallen out of medical care. ARTAS
Linkage Case Management is time and session limited with up to five sessions over a
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90 day period. ARTAS can provide practical assistance to the client, including providing
transportation to a clinic, making contact with the clinic, notifying a partner, getting
housing, and identifying other barriers to following through with medical care.2
Sometimes ARTAS is completed within one session.
The goal of Grady Infectious Disease Program ARTAS Program is to assist
people eligible for care in the program in enrolling in HIV medical care and related
services for the first time or reenrolling those who have fallen out of care, often due to
significant barriers.2 The ARTAS Linkage Program considers this goal important
because people who remain in care and on antiretroviral medications have better health
outcomes than those who do not. Consistent medical care and treatment also reduces
transmission of HIV to other people.
Some identified barriers include housing, transportation, employment, family
support, substance abuse, mental health, nutrition, literacy, unknown resources, and the
lack of perceived need for care. The Linkage to Care Resource Care Coordinator is
responsible for screening recently diagnosed patients for eligibility to participate,
conducting active case management, implementing a marketing plan, and creating
materials to educate potential community partners.
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CHAPTER III
METHODS AND PROCEDURES
3.1 Data Source
All health care providers diagnosing or providing care to a patient with HIV must
by law report HIV infection using the HIV/AIDS Case Report Form (O.C.G.A. §31-122(b)). Case report forms must be completed within seven days of diagnosing a patient
with HIV or AIDS or within seven days of assuming care of an HIV positive person who
is new to the provider, regardless of whether the patient has previously received care
elsewhere.57
Name-based reporting of HIV began in Georgia in 2004. Georgia law mandates
that laboratory facilities licensed in Georgia report all HIV-related laboratory tests
including undetectable viral loads and that all health care providers submit HIV case
report forms to the Georgia Department of Public Health HIV/AIDS Epidemiology
Section. Data from laboratory tests and case report forms are entered into the eHARS
(electronic HIV/AIDS Reporting System) database.
Sex, race/ethnicity, age, status of linkage, status of engagement, status of
retention, stage of diagnosis, and transmission category was stratified in the data. The
risk factors presented on a HIV case report form include sex with male, sex with female,
injection of non-prescription drugs, and heterosexual relations with a person with HIV.33
3.2 Variables
Linkage to care. Timely entry into medical care is important for treatment of HIV
and other medical conditions. Linkage is the process of assisting HIV-diagnosed clients
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into medical care with an HIV primary care provider authorized to prescribe HAART
medications following the receipt of a HIV diagnosis. Linkage to medical care requires
follow-up and documentation.
Retention in care. Retention in care more closely reflects the recommended
standard of care with at least 2 HIV care visits at least 3 months apart in a year.
Viral suppression. A viral load <200 copies/ml is the important to prevent
progression to AIDS and to eliminate viral transmission. Studies have shown that viral
suppression reduces transmission by 96%.
Stage of Diagnosis. Based on the CD4 count (cells/ml), HIV infection is classified
as stage 1 (CD4 count > 500), stage 2 (200-499) and stage 3, AIDS (<200). In Stage 3
disease, or AIDS, the individual is susceptible to infections and tumors.
Transmission Category. MSM = Male to male sexual contact. IDU = Injection
drug use. MSM/IDU = Male to male sexual contact and injection drug use. HET =
Heterosexual contact with a person known to have, or to be at high risk for, HIV
infection. Other = hemophilia, blood transfusion, perinatal exposure, and risk factor not
reported or not identified.33
3.3 Inclusions and Exclusions
This analysis includes newly diagnosed adolescents aged 13-24 males and
females with a current residence in Georgia. In addition, all age groups of newly
diagnosed HIV infection were included in the study. The adolescents aged 13-24 in the
analysis were diagnosed by January 1, 2013 and living as of December 31, 2013,
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including those missing race. Data were extracted from eHARS using SAS and
Microsoft Excel. A supplementary analysis was then performed by evaluating variables
such as linked to care, retained in care, viral suppression (VS), stage of diagnosis by
CD4 count, and stratified by race/ethnicity, transmission category, and age.
3.4 Statistical Procedure
Statistical Analysis System (SAS) 9.4 was used to prepare data as well as
analyze data and run statistical tests. Descriptive statistics were derived from the
demographic variables using SAS. Prevalence of HIV positive individuals was derived
from the data. Univariate logistic regression analyses were performed on HIV infected
persons to determine their association with risk factors, which included race, gender,
sex with male, sex with female, ever used injection non-prescription drugs, and
heterosexual relations with person with HIV or at risk for HIV infection. A forward
stepwise logistic regression analysis was performed on each dependent variable to
determine which risk factors were the strongest predictors for each disease.
3.5 Anti-Retroviral Treatment Access to Services (ARTAS) Intervention
Inferential data was obtained from narrative reports of de-identified client-level
from the Anti-Retroviral Treatment Access to Services (ARTAS) Intervention at Grady
IDP. Narrative Progress Reports were summarized toward contract deliverables
including testing performed, percent of goals reached, and populations tested positive
and linked to care from 2013-2015. Success and accomplishments during the period
were recorded in the ARTAS Linkage to Care Program. Plans for corrections and
improvement were noted if ARTAS fell below the target or behind schedule.
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CHAPTER IV
RESULTS
4.1 Georgia Care Continuum, 2013

Figure 1 shows the HIV care continuum stratified by different age groups in
Georgia in 2013. Adolescents aged 13-24 reports the second highest number of newly
diagnosed HIV infection among the other age groups. Although these numbers may not
seem significantly different, adolescents have the lowest linkage to care, retention in
care, and viral suppression percentages in comparison to counter age groups.
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Figure 2 looks at the number reported for each stage of diagnosis by age group
after attending HIV medical care appointment in 2013. The data indicates adolescents
aged 13-24 years old have the second highest reported rate of acute infection after 3
months and 12 months when attending their HIV medical appointment. It is also
important to notice adolescents aged 13-24 have the second highest rate of diagnosis
for stage 1 and stage 2 in 3 months and 12 months after medical appointments. These
numbers show compliancy with HIV medical care appointments lead to viral
suppression.
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Figure 3 shows a breakdown of the transmission category by different age
groups. MSM was the highest transmission category among adolescents aged 13-24
years old and adults aged 24-34 years old. Injection drug use and MSM/injection drug
use were the lowest transmission categories reported among all age groups. The
prominence of MSM transmission noted in 13-24 year olds and 25-34 year olds can be
further evaluated when discussing social and structural barriers among this
transmission group, which numbers alone cannot explain.
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Figure 4 shows the number of newly HIV positive diagnosed in Georgia in 2013
categorized by race/ethnicity. The data found HIV positive rates were high among
Black/African Americans and Whites. Transmission categories, particularly MSM,
influence the high infection seen in Blacks and Whites. Hispanic/Latinos showed the
have the lowest rate of HIV infection among the other race/ethnicities.
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OR (95% CI)

Linkage to Care

Retention in Care

Viral Suppression

Age

*0.87 (0.82, 0.94)

0.94 (0.88, 1.01)

*0.90 (0.84, 0.96)

Sex

*0.78 (0.62, 0.97)

*0.77 (0.62, 0.95)

0.94 (0.77, 1.14)

Race

0.99 (0.91,1.07)

0.94 (0.87, 1.01)

*0.89 (0.83, 0.95)

Transmission Category

1.04 (0.99, 1.10)

*1.11 (1.06, 1.17)

1.05 (1.00, 1.10)

*indicates significant association

Table 1 shows the measures of association of linkage to care, retention in care,
and viral suppression by age, sex, race, and transmission category. The referent groups
in each variable were assigned as: 13-24 age group, male sex, Blacks race, and MSM
transmission category. This data indicates 13-24 year olds are less likely to be linked to
care and virally suppressed than the other age groups. Males are less likely than
women to be linked to care and retained to care. Blacks are less likely to be virally
suppressed. MSM are less likely to be retained in care.
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4.2 Anti-Retroviral Treatment Access to Services (ARTAS) Intervention
The ARTAS Linkage to Care Program supported by Georgia Department of Public
Health through Grady IDP was able to successfully link clients to medical care while
assisting them in removing the barriers to their medical care. Some of those barriers
included: substance abuse treatment, housing, and identification for registration to
healthcare, linkage to medical case management, nutrition assistance and
transportation. A few stories in particular were pulled out to compare and contrast the
barriers found among various age groups.
Age 13-24:
! Client One: A 25-year-old male recently moved to Atlanta, GA area and was
previously diagnosed with HIV in 2009. He was actively in care in another state but
become homeless as he moved to Atlanta, GA. He was hospitalized for 3 weeks in
Grady’s impatient unit and was connected with the Linkage Coordinator from ARTAS
and was assisted with enrollment and housing. In addition to housing, he was able to
secure employment with aid in him remaining actively engaged in medical care. He
is actively engaged in medical care and successfully completed the ARTAS
intervention. His barriers included: homelessness and lack of income.
! Client Two: A 19-year-old male (along with his father) is homeless and newly
diagnosed with HIV. He was assisted with enrollment into medical care at Grady IDP
and referred to an agency for emergency lodging. Since he has been lodged, he has
made his next two medical appointments and his father secured stable employment.
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He is currently actively enrolled in medical care and successfully completed the
ARTAS intervention.
! Client Three: An 18 year-old newly diagnosed African-American MSM came to
Grady IDP the day after his initial HIV diagnosis at another facility. Someone else at
this facility told him about Grady IDP. Before he came, he expressed he was
nervous and anxious about what’s next. He is being seen at a Pediatric/Adolescent
Clinic and mother accompanies him to some appointment. He started medication on
Wednesday, April 20, 2014.

Age 25 and over:
! Client Four: A 48-year-old transgender female was enrolled on ARTAS while he was
a patient at the hospital. She was facing homelessness, which was a major barrier to
medical care. The client was assisted with enrollment into medical care. She was
also referred to an agency to assist with rental assistance. Her barriers included:
homelessness and lack of perceived need. She has completed ARTAS intervention
and is now committed to maintaining compliance with her healthcare.
! Client Five: ARTAS Staff encountered a 34-year-old male who came in as a walk in
client at the Grady IDP Clinic. The client said he was referred to the clinic by a friend
but did not present documents to prove that he qualified for services at the clinic.
Client also stated that he was currently homeless, which was a major barrier to care.
Client was referred to an agency to assist with his emergency housing needs and
was also referred to the health department to obtain needed documentation to enroll
in the clinic. Clinic never returned with the required documents necessary to enroll
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into medical care nor followed up with emergency housing agency. Client was given
contact information for the Linkage Coordinator and will hopefully follow up when he
is ready.
! Client Six: A 65 year-old previously diagnosed African American heterosexual male
was enrolled as a client on ARTAS program while a patient at Grady Hospital. The
client was not in outpatient HIV medical care at all. The client had a “lack of
perceived need” for medical care. After sessions with ARTAS, client became excited
about healthcare and is now making all medical appointments. He started ARV’s on
April 24, 2014.

The ARTAS Linkage to Care Program was able to successfully link clients to
medical care while assisting them in removing the barriers to their medical care. Some
of the major barriers found included substance abuse treatment, housing, identification
for registration to healthcare, linkage to medical case management, nutrition assistance,
and transportation. Clients were assisted with ways to address barriers so that medical
care continues. While the number of LGBT and youth-friendly service centers are
increasing, major barriers to connecting HIV-positive youth to care still exist. Most
interventions to address the continuum have been developed for adults. These are not
particularly generalizable to youth struggling with identity formation, economic
hardships, and unstable housing.
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CHAPTER V
DISCUSSION AND CONCLUSION
5.1. Discussion and Conclusion
Based on the data available from 2013, youths represent 6.7% of persons living
with HIV in the United States and account for 25.7% of new HIV infections. Of new HIV
infections among youths, 45.9% were among black males, the majority of which were
attributed to male-to-male sexual contact. Nationwide, the percentage of youths who
had ever been tested for HIV was low compared with other age. The higher HIV
prevalence among blacks overall, which is nearly three times higher than among
Hispanics/Latinos and nearly eight times higher than among whites. MSM are almost
forty times higher more than other me contributes to the disproportionate number of new
HIV infections among black youths and young MSM.
Because of this disparity, black youths are at higher risk for infection even with
similar levels of risk behaviors. Other research has found that among young MSM, other
factors such as stigma, discrimination, less condom use, more alcohol and drug use,
and having sex with older partners contribute to even higher risk for HIV acquisition.
This study also found that young MSM were significantly less likely to use condoms
during last sexual intercourse, more likely to drink alcohol or use drugs before last
sexual intercourse, and more likely to have four or more partners during their lifetime
compared with young men who had sexual intercourse only with females. These
behaviors are associated with substantial risk for infection. Moreover, the risk for HIV
infection doubled for MSM with a sex partner five years older and quadrupled with a sex
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partner ten years older. Although the number of new HIV infections is highest among
males, fewer males have been tested for HIV than females.
Monitoring and evaluation activities allow public health authorities and their
partners to assess the extent to which HIV Linkage programs are being implemented
and are achieving the intended objectives. Regardless of similarities, monitoring and
evaluation fluctuate in the extent to which findings at each level of service delivery can
be attributed to a specific intervention or program.
Monitoring aggregates information across sites and time and optimally serves as
a tool to highlight for program managers which program components may need to be
strengthened or modified to reach specific goals for preventing HIV. Monitoring
frequently counts the number of HIV positive people receiving HIV medical services,
such as the number of people receiving pretest counseling. Evaluation assesses the
worth or value of a program or collaboration between multiple programs over time
through more detailed analysis of their outcomes and their impact on the HIV
population.
Evaluation can potentially link observed outcomes and impacts and the program
process. This is especially true when multiple public health agencies and programs are
working together and measuring the impact of efforts by individual partners is difficult.
Tracking trends over time through routine HIV monitoring and evaluation efforts will help
program managers and decision makers in evaluating how successful programs are in
meeting HIV linkage goals. Most indicators are not designed to explain why a situation
has or has not changed but to simply measure trends over time. A plan for collecting
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and analyzing data should therefore be developed and focus on linking indicators that
are collected at the various levels of the health care system.
To address these needs, HIV/AIDS care and support data collection systems
have the objectives of ensuring equitable access to diagnosis, health care,
pharmaceuticals and comprehensive supportive services to reducing morbidity and
mortality from HIV/AIDS and related complications. These data collection systems also
are promoting opportunities for preventing HIV transmission within the delivery of care
and support services. Ultimately, data collection systems improve the quality of life of
both adults and children living with HIV/AIDS and their families.
5.2 Recommendations for Future
Along the HIV Care Continuum, adolescents and young adults appear to have
larger declines than older adults in all steps, resulting in estimated viral suppression of
less than 6% of those infected. The most striking difference between young adults and
older adults is in the number of undiagnosed youth. Approximately 80% of HIV-infected
adults are aware of their status, compared to only 40% of adolescents and young adults.
Sexual onset, particularly in young adults, may place youth at increased risk despite the
low risk perception. This contradiction likely contributes to low voluntary HIV testing
among youth with early new infections.
Targeted HIV testing in this population is urgently needed to bridge this disparity.
The American Academy of Pediatrics and U.S. CDC recommend routine HIV testing for
all individuals aged 13–64. Campaigns using social marketing to promote and normalize
HIV testing among youth have shown success at increasing HIV testing. In addition,
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venue-based testing promoting HIV testing in social venues where high-risk youth
congregate are effective in identifying high proportions of previously undiagnosed youth.
Increasing promotion, convenience, and availability of HIV testing demonstrates high
uptake rates among youth. HIV testing needs to be integrated and expanded in areas
where youth interact with the health system, particularly in sexual and reproductive
health clinics, primary care clinics, and in emergency and urgent care facilities. These,
in addition to venue-based testing, promoting recurrent testing among high-risk youth,
and normalizing HIV testing, could reduce the number of undiagnosed HIV youth.
In addition to testing, linkage to care and retention in care account for a
considerable drop off in the cascade of HIV-infected adolescents and young adults.
Approximately 30% of the diagnosed youth are linked to care and retained for one year.
Brief intensive case management and patient navigator systems have worked well with
adults and are being used in adolescent networks. Peer or clinic-based system
navigators form personal and professional relationships that break down some of the
barriers to initiating care. The Adolescent Trials Network is focusing on improving
relationships between testing sites and clinical sites, including multicultural, LGBT, and
adolescent-friendly services to improve adolescent linkage to care. However, major
barriers to linkage and retention in care exist, which include stigma, consent, payment,
housing instability or homelessness, transportation, and mental health/substance use.
HIV-infected adolescents may fall out of care when cared for in or transitioning to
adult care facilities, which are more focused on the adult environment. Early
multidisciplinary and developmentally appropriate transition preparation can assist in
transitioning youth to adult services. This transition planning ideally would address
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issues inherent in adolescent health including mental health, medication adherence,
sexuality, reproductive health, gender identity, socioeconomic and health insurance
status, stigma, disclosure, and disrupted relationships.
In addition, poor adherence among youth contributes to low viral suppression in
those accessing treatment. There is no simple solution to improve adherence among
youth. Successful adherence interventions are typically multifaceted and address
specific adherence barriers. Simplifying treatment regimens, using directly observed
therapy and cell phone reminders have shown promise in improving adherence among
HIV-infected youth. In adults, treatment of underlying depression and offering cognitive
behavioral therapy has shown to increase adherence. Research needs to explore new
areas and tailor existing interventions for HIV-infected youth, particularly those with
depression.
Although there have been significant developments in HIV prevention with preexposure prophylaxis (PrEP) and treatment as prevention for adults, these interventions
have not been sufficiently investigated, tailored, or scaled for youth. This cascade
highlights that current efforts for treating already-infected adolescents and young adults
remain a challenge. Most interventions to address the cascade have been developed
for adults. These are not particularly generalized to youth struggling with identity
formation, economic hardships, and unstable housing. Youth-focused interventions are
necessary to improve the HIV cascade for adolescents and young adults.
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